Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: MHRA (Medicines & Healthcare Products Regulatory Agency)
Insulin human
Sanofi
A10AB01
Insulin human
100unit/1ml
Solution for injection
Subcutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF:
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU STAR USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor, pharmacist or nurse. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.. – If you get any side effects, talk to your doctor, pharmacist or nurse. This inclu- des any possible side effects not listed in this leaflet. See section 4.535502 Đọc toàn bộ tài liệu535502 SAP-NR. (DMC): 535502 CODE: 1385 SCHRIFTGRÖSSE: 9 PUNKT DRUCKFARBEN: PANTONE REFLEX BLUE FORMAT 420 X 296 MM ERSTELLT AM: 17. NOVEMBER 2016 / VERSION: 1 / MAC 535502 WHAT IS IN THIS LEAFLET 1. What Insuman Infusat is and what it is used for 2. What you need to know before you use Insuman Infusat 3. How to use Insuman Infusat 4. Possible side effects 5. How to store Insuman Infusat 6. Contents of the pack and other information 1. WHAT INSUMAN INFUSAT IS AND WHAT IT IS USED FOR Insuman Infusat contains the active substance insulin human which is made by a biotechno- logy process and is identical with the body’s own insulin. Insuman Infusat is an insulin preparation with a rapid onset and short duration of action. Insuman Infusat must only be used in insulin pumps suitable for this insulin. Insuman Infusat is used to reduce high blood sugar in patients with diabetes mellitus who need treatment with insulin. Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE INSUMAN INFUSAT DO NOT USE INSUMAN INFUSAT If you are allergic to insulin or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before using Insuman Infusat. Follow closely the instructions for dose, moni- toring (blood and urine tests), diet and physical activity (physical work and exercise) as
OBJECT 1 INSUMAN INFUSAT 100 IU/ML SOLUTION FOR INJECTION IN A VIAL Summary of Product Characteristics Updated 16-May-2018 | SANOFI 1. Name of the medicinal product Insuman Infusat 100 IU/ml solution for injection in a vial Insuman Infusat 100 IU/ml solution for injection in a cartridge 2. Qualitative and quantitative composition Insuman Infusat 100 IU/ml in a vial Each ml contains 100 IU insulin human (equivalent to 3.5 mg). Each vial contains 10 ml of solution for injection, equivalent to 1000 IU insulin. Insuman Infusat 100 IU/ml in a cartridge Each ml contains 100 IU insulin human (equivalent to 3.5 mg). Each cartridge contains 3.15 ml of solution for injection, equivalent to 315 IU insulin. One IU (International Unit) corresponds to 0.035 mg of anhydrous human insulin * . Insuman Infusat is a neutral insulin solution (regular insulin). * Human insulin is produced by recombinant DNA technology in _Escherichia coli_. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for injection . Clear, colourless solution. 4. Clinical particulars 4.1 Therapeutic indications Diabetes mellitus where treatment with insulin is required. 4.2 Posology and method of administration Posology Insuman Infusat has been specially designed for use in external portable insulin pumps. It is specially stabilised to minimise loss of efficacy which may result from mechanical and thermal stress in such pumps. Insuman Infusat is therefore also suitable for continuous insulin infusion with other, conventional injection syringe pumps. The desired blood glucose levels and the insulin dose regimen must be determined individually and adjusted to suit the patient's diet, physical activity and life-style. _Daily doses and timing of administration _ When used in external portable insulin pumps, part of the daily insulin dose is infused continuously ("basal rate"), and the rest is administered in the form of bolus injections before meals. Refer to the operating instructions for detailed information about the infusion pump Đọc toàn bộ tài liệu